AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel

The androgen receptor splice variant (AR‐V) 7 in circulating tumor cells (CTCs) is a predictor for resistance to anti‐AR‐targeted treatment, but not to taxane‐based chemotherapy in metastatic castration‐resistant prostate cancer (mCRPC). In this study, we investigated whether the presence of two con...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Oncol
Autori principali: Sieuwerts, Anieta M., Onstenk, Wendy, Kraan, Jaco, Beaufort, Corine M., Van, Mai, De Laere, Bram, Dirix, Luc Y., Hamberg, Paul, Beeker, Aart, Meulenbeld, Hielke J., Creemers, Geert‐Jan, van Weerden, Wytske M., Jenster, Guido W., Nieuweboer, Annemieke J. M., Mathijssen, Ron H. J., de Wit, Ronald, Martens, John W. M., Sleijfer, Stefan
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Research Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6670012/
https://ncbi.nlm.nih.gov/pubmed/31180178
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12529
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi